Related references
Note: Only part of the references are listed.A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients
S. M. Hosseini-Moghaddam et al.
CLINICAL INFECTIOUS DISEASES (2019)
Optimizing the clinical utility of sirolimus-based immunosuppression for kidney transplantation
Helio Tedesco-Silva et al.
CLINICAL TRANSPLANTATION (2019)
Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation
W. A. Werbel et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
Healthcare related transmission of Pneumocystis pneumonia: From key insights toward comprehensive prevention
Mark G. J. de Boer et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort
Dionysios Neofytos et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
High-dose calcineurin inhibitor-free everolimus as a maintenance regimen for heart transplantation may be a risk factor for Pneumocystis pneumonia
Yu-Ning Hu et al.
TRANSPLANT INFECTIOUS DISEASE (2017)
Risk factors for Pneumocystis pneumonia after the first 6months following renal transplantation
Emmanuel Faure et al.
TRANSPLANT INFECTIOUS DISEASE (2017)
Pneumocystis pneumonia outbreak among renal transplant recipients at a North American transplant center: Risk factors and implications for infection control
Sunita Mulpuru et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2016)
Sirolimus and everolimus in kidney transplantation
Dirk Jan A. R. Moes et al.
DRUG DISCOVERY TODAY (2015)
Everolimus and sirolimus in transplantation-related but different
Jost Klawitter et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Risk Factors of Pneumocystis Pneumonia in Solid Organ Recipients in the Era of the Common Use of Posttransplantation Prophylaxis
X. Iriart et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
Anat Stern et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Pneumocystis Pneumonia in Solid Organ Transplantation
S. I. Martin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Post-transplant Pneumocystis jirovecii pneumonia-a re-emerged public health problem?
Jeremy R. Chapman et al.
KIDNEY INTERNATIONAL (2013)
Outbreak of Pneumocystis Pneumonia in Renal and Liver Transplant Patients Caused by Genotypically Distinct Strains of Pneumocystis jirovecii
Andreas A. Rostved et al.
TRANSPLANTATION (2013)
Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation
V. Ram Peddi et al.
TRANSPLANTATION REVIEWS (2013)
Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past
E. H. Z. Wang et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons
J. A. McKinnell et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools
Alistair B. Reid et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial
Klemens Budde et al.
LANCET (2011)
Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients
Frank Eitner et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation
Geertrude H. Struijk et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Pneumocystis jirovecii pneumonia in kidney transplantation
N. Goto et al.
TRANSPLANT INFECTIOUS DISEASE (2011)
Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis
M. G. J. de Boer et al.
TRANSPLANT INFECTIOUS DISEASE (2011)
Efficacy and Safety of Sirolimus and Everolimus in Heart Transplant Patients: A Retrospective Analysis
B. Baur et al.
TRANSPLANTATION PROCEEDINGS (2011)
Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case-control study
N. De Castro et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Genetics of early-onset obsessive-compulsive disorder
Susanne Walitza et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Analysis of USRDS: Incidence and Risk Factors for Pneumocystis jiroveci Pneumonia
Robert T. Neff et al.
TRANSPLANTATION (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
When to use the odds ratio or the relative risk?
Carsten Oliver Schmidt et al.
INTERNATIONAL JOURNAL OF PUBLIC HEALTH (2008)
Tolerance Profile of the Proliferation Signal Inhibitors Everolimus and Sirolimus in Heart Transplantation
J. A. Moro et al.
TRANSPLANTATION PROCEEDINGS (2008)
Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients:: Systematic review and meta-analysis of randomized controlled trials
Hefziba Green et al.
MAYO CLINIC PROCEEDINGS (2007)
Use of sirolimus in solid organ transplantation
Joshua J. Augustine et al.
DRUGS (2007)
Infectious risk in pediatric organ transplant recipients: Is it increased with the new immunosuppressive agents?
E Renoult et al.
PEDIATRIC TRANSPLANTATION (2005)
Benefit-risk assessment of sirolimus in renal transplantation
DRJ Kuypers
DRUG SAFETY (2005)
Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients
M Rodriguez et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Conversion to rapamycin immunosuppression in renal transplant recipients: Report of an initial experience
J Dominguez et al.
TRANSPLANTATION (2000)
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
BD Kahan
LANCET (2000)
Share Paper
